DGIdb - PPARA Gene Record

PPARA 5465 Druggable Genome

Alternate Names:

5465
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA
PPARA
NR1C1
PPAR
PPARalpha
hPPAR
170998
9232
ENSG00000186951
OTTHUMG00000150443
593
Peroxisome proliferator-activated receptor-α
peroxisome proliferator-activated receptor alpha
NP_001001928
NM_001001928
Q07869
PPAR-alpha
Nuclear receptor subfamily 1 group C member 1
PPARA_HUMAN
BE0000071
PA280
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA (PPAR-ALPHA). [SOURCE:UNIPROT/SWISSPROT;ACC:Q07869]
T86591

Gene Info:

GuideToPharmacology Gene Category Name	1C. Peroxisome proliferator-activated receptors
GuideToPharmacology Gene Category ID	86
Target Class	Receptors
Target Subclass	Nuclear receptor
Target Main Class	Receptors
Human Readable Name	NUCLEAR HORMONE RECEPTOR
Uniprot Evidence	1: Evidence at protein level
Human Readable Name	DRUGGABLE GENOME
Interpro Type	Domain
Interpro Acc	IPR000536
Uniprot Status	Swiss-Prot
Interpro Short Name	Nucl_hrmn_rcpt_lig-bd_core
Interpro Name	Nuclear hormone receptor, ligand-binding, core
Initial Gene Query	NR1C1
Counted Citations from 1950-2000	8485
Gene Biotype	PROTEIN_CODING

(13 More Sources)

Gene Categories: Category Details

TRANSCRIPTION FACTOR BINDING
NUCLEAR HORMONE RECEPTOR
DRUGGABLE GENOME
ENZYME
TRANSCRIPTION FACTOR

Publications:

Hu B et al., 2010, Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist., J Med Chem
Chaput et al., 2000, Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight., Biochem. Biophys. Res. Commun.
Casas et al., 2000, New molecular aspects of regulation of mitochondrial activity by fenofibrate and fasting., FEBS Lett.
Guerre-Millo et al., 2000, Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity., J. Biol. Chem.
Dana et al., 2001, Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat., Metab. Clin. Exp.
Clavey et al., 1999, Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells., Cell. Physiol. Biochem.
Bouly et al., 2001, Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate., J. Biol. Chem.
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
Foucher C et al., 2004, Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes., Pharmacogenetics
de Keyser CE et al., 2013, Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study., Pharmacogenomics
Tsamandouras N et al., 2014, Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach., Clin Pharmacol Ther
Hu M et al., 2013, Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia., Pharmacogenomics
Giampietro L et al., 2012, Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs., Bioorg Med Chem Lett
Felts AS et al., 2008, Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition., J Med Chem
Laghezza A et al., 2013, New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression., J Med Chem
Kasuga J et al., 2008, SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail., Bioorg Med Chem Lett
Li J et al., 2010, Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)., J Med Chem
Goldenberg et al., 2008, Update on the use of fibrates: focus on bezafibrate., Vasc Health Risk Manag
Fruchart et al., 2006, Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism., Drugs Today
Inoue et al., 2001, The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells., Metab. Clin. Exp.
Guan et al., 2001, Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease., Kidney Int.
Bonilla et al., 2001, Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver., J. Physiol. Biochem.
Pedraza et al., 2000, Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene., Diabetes
Cabrero et al., 2000, Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes., Arch. Biochem. Biophys.
Vanden Heuvel JP et al., 2006, Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha., Toxicol Sci
Chakrabarti et al., 2003, Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models., Br. J. Pharmacol.
Egerod FL et al., 2005, Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo., Biomarkers
Pahan et al., 2002, Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes., J. Biol. Chem.
Rizvi et al., 2003, Beneficial effects of fish liver preparations of sea bass (Lates calcarifer) versus gemfibrozil in high fat diet-induced lipid-intolerant rats., J Med Food
Shoji et al., 2003, Preparation of antiserum against rat delta6-desaturase and its use to evaluate the desaturase protein levels in rats treated with gemfibrozil, a ligand for peroxisome proliferator-activated receptor alpha., Biosci. Biotechnol. Biochem.
Bossé et al., Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil., Genet. Med.
De Filippis et al., 2011, Discovery of gemfibrozil analogues that activate PPARα and enhance the expression of gene CPT1A involved in fatty acids catabolism., Eur J Med Chem
Cavender et al., 2010, Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus., Am J Cardiovasc Drugs
Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
Hunt et al., 2000, Involvement of the peroxisome proliferator-activated receptor alpha in regulating long-chain acyl-CoA thioesterases., J. Lipid Res.
Casas et al., 2000, A 45 kDa protein related to PPARgamma2, induced by peroxisome proliferators, is located in the mitochondrial matrix., FEBS Lett.
Palkar et al., 2010, Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development., Toxicology
Kömüves et al., 2000, Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo., J. Invest. Dermatol.
Gelosa et al., 2010, Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats., J. Pharmacol. Exp. Ther.
Barclay et al., 1999, Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent., J. Pharmacol. Exp. Ther.
Murata et al., 2000, Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro., Biochem. Biophys. Res. Commun.
Lunde I et al., 2014, The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients., Eur J Clin Pharmacol
Elens L et al., 2013, Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus., Pharmacogenet Genomics
Lancia P et al., 2018, Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus., Pediatr Nephrol
Tamasi et al., 2008, Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators., Mol. Pharmacol.
Kohalmy et al., 2007, Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor., Drug Metab. Dispos.
Jia Y et al., 2011, Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism., Bioorg Med Chem Lett
Bhurruth-Alcor Y et al., 2010, Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPAR alpha selective., Bioorg Med Chem Lett
Hoang MH et al., 2012, Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells., Bioorg Med Chem Lett
Sato A et al., 2013, Synthesis and evaluation of 2,3-dinorprostaglandins: Dinor-PGD1 and 13-epi-dinor-PGD1 are peroxisome proliferator-activated receptor α/γ dual agonists., Bioorg Med Chem Lett
Goswami S et al., 2014, Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin., Clin Pharmacol Ther
Sarath Josh MK et al., 2014, Phthalates efficiently bind to human peroxisome proliferator activated receptor and retinoid X receptor α, β, γ subtypes: an in silico approach., J Appl Toxicol
Asano M et al., 2012, Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists., Bioorg Med Chem Lett
Cano C et al., 2007, Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activation., J Med Chem
Piemontese L et al., 2015, Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175., Eur J Med Chem
Kajita D et al., 2015, Design and synthesis of silicon-containing fatty acid amide derivatives as novel peroxisome proliferator-activated receptor (PPAR) agonists., Bioorg Med Chem Lett
Tenenbaum et al., 2005, Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons., Cardiovasc Diabetol
van Eekeren IC et al., 2013, Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review., Ther Adv Musculoskelet Dis
Murakami et al., 1999, Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha., Biochem. Biophys. Res. Commun.
Lehmann et al., 1997, Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs., J. Biol. Chem.
Botton MR et al., 2015, PPARA gene and phenprocoumon: a new predictor of response variability., Pharmacogenet Genomics
Konno H et al., 2013, Melinjo (Gnetum gnemon L.) Seed Extract Decreases Serum Uric Acid Levels in Nonobese Japanese Males: A Randomized Controlled Study., Evid Based Complement Alternat Med
Urizar NL et al., 2002, A natural product that lowers cholesterol as an antagonist ligand for FXR., Science
Drevon CA, 2005, Fatty acids and expression of adipokines., Biochim Biophys Acta
Inoue et al., 2002, Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB., Biochem. Biophys. Res. Commun.
Erbe DV et al., 2005, Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms., Mol Pharmacol
Mezei O et al., 2003, Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells., J Nutr
Szalowska E et al., 2014, Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices., PLoS One
McCarthy TC et al., 2004, Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation., J Pharmacol Exp Ther
Rudkowska I et al., 2009, Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism., Genes Nutr
Liu M et al., 2014, PPARα-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis., Sci Rep
Rodríguez-Cruz M et al., 2017, Nutrigenomics of ω-3 fatty acids: Regulators of the master transcription factors., Nutrition
Downie MM et al., 2004, Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro., Br J Dermatol

LY-518674 PPARA

Interaction Score: 2.47

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name LY-674

Novel drug target Established target

Specific Action of the Ligand Agonist

PMIDs:
None found

Sources:
TdgClinicalTrial TTD GuideToPharmacology ChemblInteractions
RAGAGLITAZAR PPARA

Interaction Score: 1.54

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
12970088 16240504

Sources:
TTD DrugBank GuideToPharmacology
OCTANOIC ACID PPARA

Interaction Score: 1.23

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16731579

Sources:
DrugBank
ROMAZARIT PPARA

Interaction Score: 1.23

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23515070

Sources:
TTD
TESAGLITAZAR PPARA

Interaction Score: 1.23

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
16168052

Sources:
TTD DrugBank ChemblInteractions
CHEMBL107518 PPARA

Interaction Score: 1.23

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22487179

Sources:
DTC
CHEMBL1089501 PPARA

Interaction Score: 1.23

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
20218621

Sources:
DTC
K-877 PPARA

Interaction Score: 1.23

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TTD ChemblInteractions
BEZAFIBRATE PPARA

Interaction Score: 1.15

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name CRx-401

Novel drug target Established target

Specific Action of the Ligand Agonist

PMIDs:
18629356 16511610 11172467 11422732 11519881 10909982 11752352 10933891

Sources:
TEND TdgClinicalTrial TTD DrugBank GuideToPharmacology
GW501516 PPARA

Interaction Score: 1.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name GW501516

Novel drug target Established target

PMIDs:
23566516 23843199

Sources:
DTC TdgClinicalTrial DrugBank
FENOFIBRIC ACID PPARA

Interaction Score: 1.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
22579484 21855333 23566516

Sources:
DTC ChemblInteractions
ALEGLITAZAR PPARA

Interaction Score: 1.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

Trial Name aleglitazar, R1439

PMIDs:
20653327 10592235

Sources:
TdgClinicalTrial DrugBank ChemblInteractions
CIPROFIBRATE PPARA

Interaction Score: 1.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Details of the Assay for Interaction Transactivation of a GAL4-PPARα ligand binding domain construct.

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
16731579

Sources:
DTC TTD DrugBank GuideToPharmacology
GW590735 PPARA

Interaction Score: 0.93

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
10592235

Sources:
DrugBank ChemblInteractions
NAVEGLITAZAR PPARA

Interaction Score: 0.93

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name LY519818 , LY818

Novel drug target Established target

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TdgClinicalTrial TTD ChemblInteractions
IMIGLITAZAR PPARA

Interaction Score: 0.93

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TTD GuideToPharmacology ChemblInteractions
DRF-10945 PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
REGLITAZAR PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
DrugBank GuideToPharmacology
CHOLINE FENOFIBRATE PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
OLEOYLETHANOLAMIDE PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
26071639 17228882

Sources:
DTC
CHEMBL270960 PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
ZYH7 PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
CHEMBL500272 PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Specific Action of the Ligand Antagonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CP-778875 PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
AVE8134 PPARA

Interaction Score: 0.62

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
ChemblInteractions
GEMFIBROZIL PPARA

Interaction Score: 0.57

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

Direct Interaction? True

PMIDs:
12244038 12935323 12834305 12172398 10494028 21889235

Sources:
TEND DTC TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
ELAIDIC ACID PPARA

Interaction Score: 0.49

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
15491415 10403814 16731579

Sources:
DrugBank
PIRINIXIC ACID PPARA

Interaction Score: 0.49

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23171045 17228882 25497132

Sources:
DTC
CLOFIBRATE PPARA

Interaction Score: 0.49

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

Direct Interaction? True

PMIDs:
10787442 10922459 20637823 10951268 20671072 10454501 10753628

Sources:
TEND TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions
INDEGLITAZAR PPARA

Interaction Score: 0.46

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor agonist

Direct Interaction yes

PMIDs:
10592235

Sources:
DrugBank ChemblInteractions
LEUKOTRIENE_B4 PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

activator (activating)

Interaction Info:

PMIDs:
15491415

Sources:
DrugBank
STEARIC ACID PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10403814

Sources:
DrugBank
CLINOFIBRATE PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11779144

Sources:
DrugBank
MYRRH PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
11988537

Sources:
DrugBank
MURAGLITAZAR PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name muraglitazar, BMS-298585

Novel drug target Established target

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TdgClinicalTrial TTD DrugBank ChemblInteractions
ELAFIBRANOR PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD DrugBank
LXR-623 PPARA

Interaction Score: 0.41

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
20350005

Sources:
DTC
ERTIPROTAFIB PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
15475571

Sources:
DrugBank
LY-510929 PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
EDAGLITAZONE PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Details of the Assay for Interaction Measuring agonist-induced cofactor recruitment.

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
LACTOFEN PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
OXEGLITAZAR PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
LOBEGLITAZONE PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
CHEMBL410478 PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CHEMBL292352 PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
MK-0767 PPARA

Interaction Score: 0.31

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Endogenous Drug? False

Specific Action of the Ligand Agonist

PMIDs:
None found

Sources:
GuideToPharmacology
FENOFIBRATE PPARA

Interaction Score: 0.3

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

Trial Name ABT-335, choline fenofibrate,TriLipix

PMIDs:
10799317 11018525 10828060 11474486 10494028 11342537 11752352 15608561

Sources:
TEND PharmGKB TdgClinicalTrial TTD DrugBank GuideToPharmacology ChemblInteractions
ISOFLAVONE PPARA

Interaction Score: 0.25

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
12730403

Sources:
DrugBank
FENOPROFEN PPARA

Interaction Score: 0.25

Interaction Types & Directionality:

activator (activating)

Interaction Info:

PMIDs:
9013583

Sources:
DrugBank
PROSTAGLANDIN D2 PPARA

Interaction Score: 0.25

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23566516

Sources:
DTC
CHEMBL220087 PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
CIGLITAZONE PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23566516

Sources:
DTC
SODELGLITAZAR PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
IOXYNIL PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
FARGLITAZAR PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
GSK-9578 PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology
CHEMBL259327 PPARA

Interaction Score: 0.21

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
PHENPROCOUMON PPARA

Interaction Score: 0.18

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
25461249

Sources:
PharmGKB
DOCONEXENT PPARA

Interaction Score: 0.17

Interaction Types & Directionality:

ligand

Interaction Info:

PMIDs:
19585164 24986106

Sources:
DrugBank
BROMOXYNIL PPARA

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
PHENFORMIN HYDROCHLORIDE PPARA

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
TETRADECYLTHIOACETIC ACID PPARA

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
20036122

Sources:
DTC
CHEMBL118417 PPARA

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
LUCINACTANT PPARA

Interaction Score: 0.14

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10403814

Sources:
DrugBank
GW7647 PPARA

Interaction Score: 0.13

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

Direct Interaction? False

PMIDs:
23102891 18665581 23171045 18162399

Sources:
DTC GuideToPharmacology
PHTHALIC ACID PPARA

Interaction Score: 0.12

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23843199

Sources:
DrugBank
FLUFENAMIC ACID PPARA

Interaction Score: 0.12

Interaction Types & Directionality:

activator (activating)

Interaction Info:

PMIDs:
9013583

Sources:
DrugBank
FISH OIL TRIGLYCERIDES PPARA

Interaction Score: 0.12

Interaction Types & Directionality:

modulator

Interaction Info:

PMIDs:
28760435

Sources:
DrugBank
ARACHIDONIC ACID PPARA

Interaction Score: 0.12

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
15491415 10403814

Sources:
DrugBank
DODECANOATE PPARA

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10403814

Sources:
DrugBank
ICOSAPENT PPARA

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10403814

Sources:
DrugBank
LINOLEIC ACID PPARA

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
URSOLIC ACID PPARA

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
21855333

Sources:
DTC
CHEMBL153057 PPARA

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
DEXIBUPROFEN PPARA

Interaction Score: 0.09

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9013583

Sources:
DrugBank
MYRISTIC ACID PPARA

Interaction Score: 0.09

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10403814

Sources:
DTC DrugBank
CHEMBL38508 PPARA

Interaction Score: 0.09

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
OLEIC ACID PPARA

Interaction Score: 0.08

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
T091317 PPARA

Interaction Score: 0.08

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
20350005

Sources:
DTC
TACROLIMUS PPARA

Interaction Score: 0.07

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24658827 24113216 29399716

Sources:
PharmGKB
PRASTERONE PPARA

Interaction Score: 0.07

Interaction Types & Directionality:

activator (activating)

Interaction Info:

PMIDs:
18079279 17591676

Sources:
DrugBank
AMIODARONE PPARA

Interaction Score: 0.07

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
24489787 15265979

Sources:
DrugBank
LINOLENIC ACID PPARA

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10403814 16731579

Sources:
DrugBank
ROSIGLITAZONE PPARA

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
15949695 11779144

Sources:
DrugBank
SIMVASTATIN PPARA

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23930676 24598718 23252946

Sources:
PharmGKB
ILOPROST PPARA

Interaction Score: 0.04

Interaction Types & Directionality:

activator (activating)

Interaction Info:

Notes

PMIDs:
None found

Sources:
TALC
TROGLITAZONE PPARA

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11779144

Sources:
DrugBank
METFORMIN PPARA

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24853734

Sources:
PharmGKB
IBUPROFEN PPARA

Interaction Score: 0.03

Interaction Types & Directionality:

activator (activating)

Interaction Info:

PMIDs:
9013583

Sources:
DrugBank
INDOMETHACIN PPARA

Interaction Score: 0.03

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
9013583

Sources:
DrugBank
BITHIONOL PPARA

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
RESVERATROL PPARA

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24454499

Sources:
DrugBank

Ensembl: ENSG00000186951
- Version: 101_38
Alternate Names:

PPARA Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:
TdgClinicalTrial: Q07869
- Version: January-2014
Alternate Names:

PPARA Gene Symbol

Gene Info:

Target Class Receptors

Target Subclass Nuclear receptor

Publications:
HopkinsGroom: Q07869
- Version: 11-September-2012
Alternate Names:

5465 Entrez Gene Id

PPARA_HUMAN Uniprot Id

ENSG00000186951 Ensembl Gene Id

Gene Info:

Uniprot Evidence 1: Evidence at protein level

Human Readable Name DRUGGABLE GENOME

Interpro Type Domain

Gene Categories:

NUCLEAR HORMONE RECEPTOR, DRUGGABLE GENOME

Publications:
TEND: Q07869
- Version: 01-August-2011
Alternate Names:

PPARA_HUMAN Uniprot Id

PPARA Gene Symbol

5465 Entrez Gene Id

Gene Info:

Target Main Class Receptors

Target Subclass Nuclear receptor

Publications:
RussLampel: ENSG00000186951
- Version: 26-July-2011
Alternate Names:

PPARA Display Id

ENSG00000186951 Ensembl Gene Id

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA (PPAR-ALPHA). [SOURCE:UNIPROT/SWISSPROT;ACC:Q07869] Description

Gene Info:

Human Readable Name DRUGGABLE GENOME

Gene Categories:

DRUGGABLE GENOME

Publications:
BaderLabGenes: PPARA
- Version: February-2014
Alternate Names:

5465 Entrez Gene ID

Gene Info:

Initial Gene Query NR1C1

Counted Citations from 1950-2000 8485

Gene Categories:

NUCLEAR HORMONE RECEPTOR

Publications:
GuideToPharmacology: 5465
- Version: 29-September-2020
Alternate Names:

9232 HUGO Gene ID

9232 HUGO Gene Symbol

peroxisome proliferator activated receptor alpha HUGO Gene Name

Gene Info:

GuideToPharmacology Gene Category Name 1C. Peroxisome proliferator-activated receptors

GuideToPharmacology Gene Category ID 86

Gene Categories:

NUCLEAR HORMONE RECEPTOR

Publications:

PharmGKB: PPARA

Version: 18-August-2020

Alternate Names:

PA280 PharmGKB ID

Gene Info:

Publications:

de Keyser CE et al., 2013, Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study., Pharmacogenomics

Tsamandouras N et al., 2014, Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach., Clin Pharmacol Ther

Hu M et al., 2013, Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia., Pharmacogenomics

DrugBank: BE0000071

Version: 5.1.7

Alternate Names:

PPARA DrugBank Gene Name

Q07869 UniProt Accession

5465 Entrez Gene Id

Gene Info:

Publications:

Murakami et al., 1999, Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha., Biochem. Biophys. Res. Commun.

Inoue et al., 2002, Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB., Biochem. Biophys. Res. Commun.

Szalowska E et al., 2014, Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices., PLoS One

TTD: Peroxisome proliferator-activated receptor alpha
- Version: 2020.06.01
Alternate Names:

PPARA TTD Gene Abbreviation

T86591 TTD Target ID

Gene Info:

Publications:

van Eekeren IC et al., 2013, Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review., Ther Adv Musculoskelet Dis

DTC: PPARA

Version: 02-September-2020

Alternate Names:

Gene Info:

Publications:

Laghezza A et al., 2013, New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression., J Med Chem

Cano C et al., 2007, Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activation., J Med Chem

Piemontese L et al., 2015, Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175., Eur J Med Chem

HingoraniCasas: ENSG00000186951
- Version: 31-May-2017
Alternate Names:

ENSG00000186951 Gene Symbol

PPARA Ensembl Id

Gene Info:

Gene Categories:

DRUGGABLE GENOME

Publications:
TALC: PPAR
- Version: 12-May-2016
Alternate Names:

PPAR Gene Symbol

Gene Info:

Publications:
ChemblInteractions: NR1C1
- Version: chembl_23
Alternate Names:

PPAR GENE_SYMBOL

PPARA GENE_SYMBOL

Peroxisome proliferator-activated receptor alpha UNIPROT

Gene Info:

Publications:
Pharos: PPARA
- Version: 03-September-2020
Alternate Names:

Peroxisome proliferator-activated receptor alpha Gene Name

Q07869 UniProt ID

Gene Info:

Gene Categories:

ENZYME, TRANSCRIPTION FACTOR

Publications:
GO: PPARA
- Version: 05-September-2020
Alternate Names:

NR1C1 GO Gene Synonym

PPAR GO Gene Synonym

Gene Info:

Gene Categories:

TRANSCRIPTION FACTOR BINDING, NUCLEAR HORMONE RECEPTOR

Publications:
dGene: PPARA
- Version: 27-Jun-2013
Alternate Names:

5465 Gene ID

NR1C1 dGene Synonym

PPAR dGene Synonym

Gene Info:

Gene Categories:

NUCLEAR HORMONE RECEPTOR

Publications:

Trial Name	LY-674
Novel drug target	Established target
Specific Action of the Ligand	Agonist

Mechanism of Interaction	Peroxisome proliferator-activated receptor alpha agonist
Direct Interaction	yes

Trial Name	CRx-401
Novel drug target	Established target
Specific Action of the Ligand	Agonist

Details of the Assay for Interaction	Transactivation of a GAL4-PPARα ligand binding domain construct.
Specific Action of the Ligand	Agonist
Endogenous Drug?	False

Trial Name	LY519818 , LY818
Novel drug target	Established target
Mechanism of Interaction	Peroxisome proliferator-activated receptor alpha agonist

Specific Action of the Ligand	Antagonist
Endogenous Drug?	False

Trial Name	muraglitazar, BMS-298585
Novel drug target	Established target
Mechanism of Interaction	Peroxisome proliferator-activated receptor alpha agonist

Details of the Assay for Interaction	Measuring agonist-induced cofactor recruitment.
Specific Action of the Ligand	Agonist
Endogenous Drug?	False

5465	Entrez Gene Id
PPARA_HUMAN	Uniprot Id
ENSG00000186951	Ensembl Gene Id

PPARA	Display Id
ENSG00000186951	Ensembl Gene Id
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA (PPAR-ALPHA). [SOURCE:UNIPROT/SWISSPROT;ACC:Q07869]	Description

9232	HUGO Gene ID
9232	HUGO Gene Symbol
peroxisome proliferator activated receptor alpha	HUGO Gene Name

PPARA	DrugBank Gene Name
Q07869	UniProt Accession
5465	Entrez Gene Id

PPAR	GENE_SYMBOL
PPARA	GENE_SYMBOL
Peroxisome proliferator-activated receptor alpha	UNIPROT

Peroxisome proliferator-activated receptor alpha	Gene Name
Q07869	UniProt ID

PPARA Gene Record

PPARA 5465 Druggable Genome

Alternate Names:

Gene Info:

Gene Categories: Category Details

Publications:

Interaction Types & Directionality: agonist (activating)

Interaction Info: Trial Name LY-674 Novel drug target Established target Specific Action of the Ligand Agonist

PMIDs: None found

Sources: TdgClinicalTrial TTD GuideToPharmacology ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Specific Action of the Ligand Agonist Endogenous Drug? False

PMIDs: 12970088 16240504

Sources: TTD DrugBank GuideToPharmacology

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16731579

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 23515070

Sources: TTD

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist Direct Interaction yes

PMIDs: 16168052

Sources: TTD DrugBank ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22487179

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 20218621

Sources: DTC

Interaction Types & Directionality: agonist (activating)

Interaction Info: Direct Interaction yes Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs: None found

Sources: TTD ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Trial Name CRx-401 Novel drug target Established target Specific Action of the Ligand Agonist

PMIDs: 18629356 16511610 11172467 11422732 11519881 10909982 11752352 10933891

Sources: TEND TdgClinicalTrial TTD DrugBank GuideToPharmacology

Interaction Types & Directionality: agonist (activating)

Interaction Info: Trial Name GW501516 Novel drug target Established target

PMIDs: 23566516 23843199

Sources: DTC TdgClinicalTrial DrugBank

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist Direct Interaction yes

PMIDs: 22579484 21855333 23566516

Sources: DTC ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist Direct Interaction yes Trial Name aleglitazar, R1439

PMIDs: 20653327 10592235

Sources: TdgClinicalTrial DrugBank ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Details of the Assay for Interaction Transactivation of a GAL4-PPAR&alpha; ligand binding domain construct. Specific Action of the Ligand Agonist Endogenous Drug? False

PMIDs: 16731579

Sources: DTC TTD DrugBank GuideToPharmacology

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist Direct Interaction yes

PMIDs: 10592235

Sources: DrugBank ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Trial Name LY519818 , LY818 Novel drug target Established target Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs: None found

Sources: TdgClinicalTrial TTD ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Specific Action of the Ligand Agonist Endogenous Drug? False Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs: None found

Sources: TTD GuideToPharmacology ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Specific Action of the Ligand Agonist Endogenous Drug? False

PMIDs: None found

Sources: DrugBank GuideToPharmacology

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist Direct Interaction yes

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name LY-674

Novel drug target Established target

Specific Action of the Ligand Agonist

PMIDs:
None found

Sources:
TdgClinicalTrial TTD GuideToPharmacology ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
12970088 16240504

Sources:
TTD DrugBank GuideToPharmacology

Interaction Types & Directionality:

n/a

PMIDs:
16731579

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
23515070

Sources:
TTD

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
16168052

Sources:
TTD DrugBank ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
22487179

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
20218621

Sources:
DTC

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TTD ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name CRx-401

Novel drug target Established target

Specific Action of the Ligand Agonist

PMIDs:
18629356 16511610 11172467 11422732 11519881 10909982 11752352 10933891

Sources:
TEND TdgClinicalTrial TTD DrugBank GuideToPharmacology

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name GW501516

Novel drug target Established target

PMIDs:
23566516 23843199

Sources:
DTC TdgClinicalTrial DrugBank

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
22579484 21855333 23566516

Sources:
DTC ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

Trial Name aleglitazar, R1439

PMIDs:
20653327 10592235

Sources:
TdgClinicalTrial DrugBank ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Details of the Assay for Interaction Transactivation of a GAL4-PPARα ligand binding domain construct.

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
16731579

Sources:
DTC TTD DrugBank GuideToPharmacology

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
10592235

Sources:
DrugBank ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name LY519818 , LY818

Novel drug target Established target

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TdgClinicalTrial TTD ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

PMIDs:
None found

Sources:
TTD GuideToPharmacology ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
DrugBank GuideToPharmacology

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
26071639 17228882

Sources:
DTC

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Specific Action of the Ligand Agonist

Endogenous Drug? False

PMIDs:
None found

Sources:
GuideToPharmacology

Interaction Types & Directionality:

agonist (activating)